Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore to its SAB Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore to its SAB As Chair of the Board, Dr Michael Murray will work with the team to accelerate the company’s growth, while Dr Moore will join the scientific advisory board to support the... CTMC appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer CTMC appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer Pharma Tech Industries names Jack Milligan as VP of Business Development Pharma Tech Industries names Jack Milligan as VP of Business Development WLS promotes Michael Mora to Machine Reliability Manager WLS promotes Michael Mora to Machine Reliability Manager CARBOGEN AMCIS announces leadership transition CARBOGEN AMCIS announces leadership transition Admix Europe ApS appoints Jakob Iversholt as new Operations Manager Admix Europe ApS appoints Jakob Iversholt as new Operations Manager Touchlight appoints Will Downie as adviser to support strategic growth in synthetic DNA platforms Touchlight appoints Will Downie as adviser to support strategic growth in synthetic DNA platforms Touchlight, a pioneering leader in synthetic DNA technology, is pleased to announce the appointment of Will Downie as a key adviser to support its mission in advancing genetic... Syntegon appoints Eros Carletti as Chief Financial Officer Syntegon appoints Eros Carletti as Chief Financial Officer Replacing Dr Peter Hackel, Eros will champion the group's global growth Servier names David K. Lee Executive VP of the United States Servier names David K. Lee Executive VP of the United States As Executive Vice President, David will lead Servier's activities in the US and help to form its market strategy in this key region Admix Europe APS appoints Jonas Öberg as Managing Director for European Operation Admix Europe APS appoints Jonas Öberg as Managing Director for European Operation Öberg, from Sweden, brings extensive international industrial experience as he has held numerous leadership positions, overseen manufacturing sites and commercial operations... From RAGs to riches: AI in pharma From RAGs to riches: AI in pharma Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier, reflects on the growth and future of AI in the pharmaceutical industry Fast forward PGx research in 2025 Fast forward PGx research in 2025 Neil Ward, VP EMEA of PacBio, takes a look at the near-term future of pharmacogenes BeiGene appoints Giancarlo Benelli as Senior VP and Head of Europe BeiGene appoints Giancarlo Benelli as Senior VP and Head of Europe Giancarlo will assist the company in its efforts to bring oncology medicines to more European patients AstraZeneca appoints Iskra Reic as its International Executive Vice President AstraZeneca appoints Iskra Reic as its International Executive Vice President Iskra will be responsible for championing AstraZeneca's growth across key markets globally, as well as business strategy development Ann-Xiaoyan Li appointed new Group CFO and Managing Director of the Romaco Group Ann-Xiaoyan Li appointed new Group CFO and Managing Director of the Romaco Group New member on the Romaco Group Board of Management Merck appoints Surendralal L. Karsanbhai to its board of directors Merck appoints Surendralal L. Karsanbhai to its board of directors The President and CEO of Emerson Electric will work with the 13-strong board to oversee the management of Merck's global business endeavours Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas Biosynth appoints Matt Gunnison as its new CEO and Kieran Murphy as Chair Biosynth appoints Matt Gunnison as its new CEO and Kieran Murphy as Chair Matt and will both assume their places on the Board of Directors, and will work to strengthen the company's position in the life sciences sector Wheeler Bio appoints Patrick Lucy as chief executive officer Wheeler Bio appoints Patrick Lucy as chief executive officer Experienced leader to guide the company towards integrated commercial-scale operations Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board The two will work to advance the company's global presence, while developing its lead programme Mosaic Therapeutics appoints Dr Barry Davies as its CSO Mosaic Therapeutics appoints Dr Barry Davies as its CSO Barry will bring more than 25 years of experience in drug development and lead optimisation to the table Lonza nominates David Meline as independent board member Lonza nominates David Meline as independent board member David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors Nanosyrinx appoints Edwin Moses as its Chairperson Nanosyrinx appoints Edwin Moses as its Chairperson With more than 30 years of executive-level experience, Edwin will aim to maximise the value of the company's nanosyringe platform Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility The CDMO has appointed Norm to run the USD $50m manufacturing facility in New Jersey